Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Overview of attention for article published in Cardiovascular Diabetology, October 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 86 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,334 followers.

【GLP-1アナログで血糖管理不十分。次の一手は？：ESCEL後付解析/ Cardiovasc Diabetol】 CV高リスク２型DM、傾向スコアマッチ約1500例比較：GLP-1アナログにSGLT2阻害薬併用で、GLP-1アナログのみに比べ、MACE補正後HRは0.85 [95%CI 0.48-1.49]。死亡は0.41 [0.17-0.95]。 https://t.co/ANg1nxcYUo https://t.co/C4aKmI95gC

23 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.